abstract |
N- (2-hydroxyethyl) piperazine-N ′ (3-propanesulfonic acid) (EPPS), pharmaceutically acceptable salt or derivative thereof, and donepezil, pharmaceutically acceptable salt or derivative thereof The present invention relates to a pharmaceutical composition for the prevention or treatment of cognitive impairment-related diseases, which is used for the prevention or treatment of cognitive impairment-related diseases. |